Hochstetler A, Hehnly C, Dawes W, Harris D, Sadegh C, Mangano F
Fluids Barriers CNS. 2025; 22(1):24.
PMID: 40033423
PMC: 11877769.
DOI: 10.1186/s12987-025-00632-1.
Yoshida T, Yang Z, Ashida S, Yu Z, Shrivastav S, Rojulpote K
bioRxiv. 2025; .
PMID: 39803526
PMC: 11722280.
DOI: 10.1101/2024.12.28.630625.
Courtney Y, Hochstetler A, Lehtinen M
Annu Rev Pathol. 2024; 20(1):193-220.
PMID: 39383438
PMC: 11884907.
DOI: 10.1146/annurev-pathmechdis-051222-114051.
Mirkhaef S, Harbaugh L, Nagra G
Cureus. 2024; 16(9):e68516.
PMID: 39364470
PMC: 11448269.
DOI: 10.7759/cureus.68516.
Barrett E, Ivey G, Cunningham A, Coffman G, Pemberton T, Lee C
Front Aging Neurosci. 2024; 16:1350239.
PMID: 38915346
PMC: 11194438.
DOI: 10.3389/fnagi.2024.1350239.
Mechanisms of cerebrospinal fluid secretion by the choroid plexus epithelium: Application to various intracranial pathologies.
Johnsen L, Friis K, Moller-Madsen M, Damkier H
Clin Anat. 2024; 38(1):63-74.
PMID: 38894645
PMC: 11652798.
DOI: 10.1002/ca.24199.
Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models.
Hochstetler A, Smith H, Reed M, Hulme L, Territo P, Bedwell A
Fluids Barriers CNS. 2023; 20(1):61.
PMID: 37596666
PMC: 10439616.
DOI: 10.1186/s12987-023-00461-0.
Mechanisms of cerebrospinal fluid and brain interstitial fluid production.
Xiang J, Hua Y, Xi G, Keep R
Neurobiol Dis. 2023; 183:106159.
PMID: 37209923
PMC: 11071066.
DOI: 10.1016/j.nbd.2023.106159.
Consideration of Kinase Inhibitors for the Treatment of Hydrocephalus.
Blazer-Yost B
Int J Mol Sci. 2023; 24(7).
PMID: 37047646
PMC: 10094860.
DOI: 10.3390/ijms24076673.
Kinase Inhibitors in Genetic Diseases.
DAntona L, Amato R, Brescia C, Rocca V, Colao E, Iuliano R
Int J Mol Sci. 2023; 24(6).
PMID: 36982349
PMC: 10048847.
DOI: 10.3390/ijms24065276.
Outcomes of the 2019 hydrocephalus association workshop, "Driving common pathways: extending insights from posthemorrhagic hydrocephalus".
Karimy J, Newville J, Sadegh C, Morris J, Monuki E, Limbrick Jr D
Fluids Barriers CNS. 2023; 20(1):4.
PMID: 36639792
PMC: 9838022.
DOI: 10.1186/s12987-023-00406-7.
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer's disease.
White H, Webb R, McKnight I, Legg K, Lee C, Lee P
Front Genet. 2022; 13:936151.
PMID: 36406122
PMC: 9670164.
DOI: 10.3389/fgene.2022.936151.
TRPV4: Cell type-specific activation, regulation and function in the vertebrate eye.
Lapajne L, Rudzitis C, Cullimore B, Ryskamp D, Lakk M, Redmon S
Curr Top Membr. 2022; 89:189-219.
PMID: 36210149
PMC: 9879314.
DOI: 10.1016/bs.ctm.2022.07.005.
Lysophosphatidic acid as a CSF lipid in posthemorrhagic hydrocephalus that drives CSF accumulation via TRPV4-induced hyperactivation of NKCC1.
Toft-Bertelsen T, Barbuskaite D, Heerfordt E, Lolansen S, Andreassen S, Rostgaard N
Fluids Barriers CNS. 2022; 19(1):69.
PMID: 36068581
PMC: 9450297.
DOI: 10.1186/s12987-022-00361-9.
Hydrocephalus: historical analysis and considerations for treatment.
Hochstetler A, Raskin J, Blazer-Yost B
Eur J Med Res. 2022; 27(1):168.
PMID: 36050779
PMC: 9434947.
DOI: 10.1186/s40001-022-00798-6.
Following Ussing's legacy: from amphibian models to mammalian kidney and brain.
Blazer-Yost B
Am J Physiol Cell Physiol. 2022; 323(4):C1061-C1069.
PMID: 36036449
PMC: 9529261.
DOI: 10.1152/ajpcell.00303.2022.
Characterization of TRPV4-mediated signaling pathways in an optimized human choroid plexus epithelial cell line.
Hulme L, Hochstetler A, Schwerk C, Schroten H, Ishikawa H, Tung C
Am J Physiol Cell Physiol. 2022; 323(6):C1823-C1842.
PMID: 35938676
PMC: 9744646.
DOI: 10.1152/ajpcell.00193.2022.
Transcriptional profiling of transport mechanisms and regulatory pathways in rat choroid plexus.
Andreassen S, Toft-Bertelsen T, Wardman J, Villadsen R, MacAulay N
Fluids Barriers CNS. 2022; 19(1):44.
PMID: 35659263
PMC: 9166438.
DOI: 10.1186/s12987-022-00335-x.
Porcine choroid plexus-Riems cell line demonstrates altered polarization of transport proteins compared with the native epithelium.
Hochstetler A, Hulme L, Delpire E, Schwerk C, Schroten H, Preston D
Am J Physiol Cell Physiol. 2022; 323(1):C1-C13.
PMID: 35508188
PMC: 9236870.
DOI: 10.1152/ajpcell.00374.2021.
Drug-Targeted Genomes: Mutability of Ion Channels and GPCRs.
Raines R, McKnight I, White H, Legg K, Lee C, Li W
Biomedicines. 2022; 10(3).
PMID: 35327396
PMC: 8945769.
DOI: 10.3390/biomedicines10030594.